透视81家创新药企三季报:亏损收窄医保放量BD增长释放什么信号?

投资时报
Nov 11

81家A股创新药上市公司归母净利润实现同比增长,增幅达13.84%,其中,9家公司由去年同期的亏损转为盈利投资时间网、标点财经研究员 李路2025年,创新药行业迎来历史性转折点。据Wind数据显示,截至10月21日,中国创新药对外授权交易总额突破千亿美元大关,达到1012.4亿美元,远超2024年全年的519亿美元。同时政策红利持续释放,2025年国家医保谈判首次引入“商保创新药目录”机制,127...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10